Back

Forward genetic screening in engineered colorectal cancer organoids identifies novel regulators of metastasis

Cramer, Z.; Wang, X.; Leu, N. A.; Monaghan, K.; Rhoades, J. H.; Tian, Y.; Rico, J.; Mendez, D.; Petroni, R.; Kim, M. S.; Matsuda, R.; Carrera, M. F.; Brodsky, I. E.; Li, N.; Lengner, C. J.; Blanco, M. A.

2023-08-05 cancer biology
10.1101/2023.08.03.551805 bioRxiv
Show abstract

Cancer is the second leading cause of death globally, due primarily to metastatic dissemination and colonization of distal sites. Recurrent genetic drivers of metastasis are elusive, suggesting that, unlike the stereotyped mutations promoting primary tumor development, drivers of metastasis may be variable. Here, we interrogate pathways governing metastasis through CRISPR/Cas9-based forward genetic screening in a genetically defined colorectal adenocarcinoma tumor organoid (tumoroid) model using ex vivo invasion screens and orthotopic, in vivo screens for gain of metastatic potential. We identify Ctnna1 and Bcl2l13 as bona fide metastasis suppressors. CTNNA1 loss promotes carcinoma cell invasion and migration through an atypical EMT-like mechanism, whereas BCL2L13 loss promotes cell survival after extracellular matrix detachment and non-cell-autonomous macrophage polarization. Ultimately, this study provides a proof-of-principle that high-content forward genetic screening can be performed in tumor-organoid models in vivo and identifies novel regulators of colon cancer metastasis.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 12%
15.0%
Similar papers in this journal
2
Nature
○ 645 papers in training set
Top 2%
7.8%
Similar papers in this journal
3
Cell
○ 431 papers in training set
Top 0.7%
7.3%
Similar papers in this journal
4
Cancer Discovery
● 66 papers in training set
Top 0.4%
5.5%
Similar papers in this journal
5
Cell Reports
○ 1498 papers in training set
Top 6%
5.5%
Similar papers in this journal
6
Nature Cancer
○ 39 papers in training set
Top 0.3%
5.4%
7
Science Advances
● 1243 papers in training set
Top 8%
4.0%
50% of probability mass above
8
eLife
● 5828 papers in training set
Top 32%
3.5%
9
Science
● 477 papers in training set
Top 2%
3.5%
10
Cancer Research
● 130 papers in training set
Top 1%
3.2%
11
Molecular Cell
○ 350 papers in training set
Top 2%
3.1%
12
Nature Genetics
○ 286 papers in training set
Top 2%
2.4%
13
Cancer Cell
○ 42 papers in training set
Top 0.5%
2.4%
14
Developmental Cell
○ 196 papers in training set
Top 2%
2.1%
15
Cell Reports Medicine
○ 153 papers in training set
Top 2%
2.1%
16
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 27%
1.7%
17
Cell Stem Cell
○ 62 papers in training set
Top 0.9%
1.7%
18
Nature Cell Biology
○ 118 papers in training set
Top 2%
1.7%
19
Nature Medicine
○ 125 papers in training set
Top 2%
1.5%
20
Cell Genomics
○ 172 papers in training set
Top 3%
1.3%
21
Cell Systems
○ 201 papers in training set
Top 4%
1.1%
22
Nature Methods
○ 385 papers in training set
Top 5%
1.1%
23
Genome Biology
○ 637 papers in training set
Top 7%
1.1%
24
Gastroenterology
○ 42 papers in training set
Top 0.8%
1.1%
25
Nature Biotechnology
○ 172 papers in training set
Top 4%
0.9%
26
Communications Biology
○ 993 papers in training set
Top 30%
0.8%
27
iScience
○ 1154 papers in training set
Top 41%
0.6%
28
npj Precision Oncology
○ 53 papers in training set
Top 2%
0.6%
29
EMBO Reports
○ 263 papers in training set
Top 8%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.